Julie E. Bauman, MD, MPH is director of the GW Cancer Center as well as associate dean of cancer and professor of medicine at the GW School of Medicine & Health Sciences.
Bauman completed a dual MD/MPH degree at Tufts University School of Medicine, internal medicine residency at the University of Utah and medical oncology fellowship at the University of Washington / Fred Hutchinson Cancer Research Center. Her education and training, at the intersection of oncology and public health, resulted in unique expertise in clinical trial design. As a recipient of the prestigious National Institutes of Health (NIH) National Cancer Institute (NCI) Clinical Investigator Team Leadership Award, Bauman is a nationally recognized leader in cancer therapeutics for both prevention and treatment, with more than 150 publications and a long track record of NIH team science funding.
Bauman is the co-principal investigator of the UA Cancer Prevention Clinical Trials Network, one of only five NCI-funded clinical trial networks devoted to drug development for cancer prevention. Her own research focuses on so-called "green chemoprevention," or the use of whole plants or their extracts for cancer prevention. Bauman also leads multiple national clinical trials for the treatment of head and neck cancer, with dedicated expertise in precision medicine and immunotherapy. She is the current co-chair of the NCI Cancer Prevention Steering Committee as well as the co-chair of the NCI Head and Neck Steering Committee’s PULA Task Force. Bauman is also a 2020 graduate of the premiere Executive Leadership in Academic Medicine fellowship for women at the Drexel University College of Medicine.